These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34901990)

  • 1. Minimally Invasive Surfactant Therapy to Prevent Bronchopulmonary Dysplasia in Extremely Preterm Infants.
    Isayama T
    JAMA; 2021 Dec; 326(24):2475-2476. PubMed ID: 34901990
    [No Abstract]   [Full Text] [Related]  

  • 2. Surfactant delivery strategies to prevent bronchopulmonary dysplasia.
    Kribs A; Roberts KD; Trevisanuto D; O'Donnell C; Dargaville PA
    Semin Perinatol; 2023 Oct; 47(6):151813. PubMed ID: 37805275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory support in preterm infants at birth.
    ;
    Pediatrics; 2014 Jan; 133(1):171-4. PubMed ID: 24379228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Ventilation Strategies to Reduce Adverse Pulmonary Outcomes.
    Keszler M
    Clin Perinatol; 2022 Mar; 49(1):219-242. PubMed ID: 35210003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory management in the premature neonate.
    Dumpa V; Avulakunta I; Bhandari V
    Expert Rev Respir Med; 2023 Feb; 17(2):155-170. PubMed ID: 36803028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBNEO Commentary: De-MIST-ifying the 2-year outcomes of non-invasive surfactant therapy.
    Loft L; Ferguson KN; Tingay DG
    Acta Paediatr; 2024 May; 113(5):1121-1122. PubMed ID: 38269640
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy of minimally invasive pulmonary surfactant administration in preterm infants with neonatal respiratory distress syndrome: a multicenter clinical trial].
    Liu HQ; Tong XM; Han TY; Zhang H; Guo M; Zhang XF; Liu XJ; Zhang X; Zhang MT; Liu F; Bao LS; Zheng J; Tian XY; Gao Q; Zhang WX; Duan Y; Sun FF; Guo W; Li L; Xiao M; Liu WL; Jiang R
    Zhonghua Er Ke Za Zhi; 2020 May; 58(5):374-380. PubMed ID: 32392952
    [No Abstract]   [Full Text] [Related]  

  • 8. Surfactant in the preterm infant: what's going on.
    Dani C; Barp J; Berti E; Bertini G
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():3-5. PubMed ID: 19925357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally Invasive Surfactant Therapy vs Sham Treatment and Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome.
    Razak A
    JAMA; 2022 Apr; 327(16):1613. PubMed ID: 35471524
    [No Abstract]   [Full Text] [Related]  

  • 10. Minimally Invasive Surfactant Therapy vs Sham Treatment and Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome.
    Zhou P; Han T
    JAMA; 2022 Apr; 327(16):1613-1614. PubMed ID: 35471523
    [No Abstract]   [Full Text] [Related]  

  • 11. Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis.
    Zhong YY; Li JC; Liu YL; Zhao XB; Male M; Song DK; Bai Y
    Curr Med Sci; 2019 Jun; 39(3):493-499. PubMed ID: 31209823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of budesonide associated with a pulmonary surfactant to prevent bronchopulmonary dysplasia in premature newborns - A systematic review.
    Moraes LHA; Coelho RMD; Neves Dos Santos Beozzo GP; Yoshida RAM; de Albuquerque Diniz EM; de Carvalho WB
    J Pediatr (Rio J); 2023; 99(2):105-111. PubMed ID: 36436670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimally Invasive Surfactant Therapy vs Sham Treatment and Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome-Reply.
    Dargaville PA; Carlin JB; Davis PG;
    JAMA; 2022 Apr; 327(16):1614-1615. PubMed ID: 35471518
    [No Abstract]   [Full Text] [Related]  

  • 14. Systematic review found that using thin catheters to deliver surfactant to preterm neonates was associated with reduced bronchopulmonary dysplasia and mechanical ventilation.
    Panza R; Laforgia N; Bellos I; Pandita A
    Acta Paediatr; 2020 Nov; 109(11):2219-2225. PubMed ID: 32441829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant phospholipids and surface activity among preterm infants with respiratory distress syndrome who develop bronchopulmonary dysplasia.
    Kazzi SN; Schürch S; McLaughlin KL; Romero R; Janisse J
    Acta Paediatr; 2000 Oct; 89(10):1218-25. PubMed ID: 11083379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "New" bronchopulmonary dysplasia and chronic lung disease.
    Voynow JA
    Paediatr Respir Rev; 2017 Sep; 24():17-18. PubMed ID: 28697967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal surfactant therapy--where do we go from here?
    Martin RJ
    J Pediatr; 1991 Apr; 118(4 Pt 1):555-6. PubMed ID: 2007929
    [No Abstract]   [Full Text] [Related]  

  • 18. Surfactant, steroids and non-invasive ventilation in the prevention of BPD.
    Dumpa V; Bhandari V
    Semin Perinatol; 2018 Nov; 42(7):444-452. PubMed ID: 30343941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation.
    Dargaville PA; Kamlin CO; De Paoli AG; Carlin JB; Orsini F; Soll RF; Davis PG
    BMC Pediatr; 2014 Aug; 14():213. PubMed ID: 25164872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate.
    Engle WA;
    Pediatrics; 2008 Feb; 121(2):419-32. PubMed ID: 18245434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.